Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-23-018061

Chief Commercial Officer sold 13,934 shares at an average $20.63 ($287,435)

  • Chief Commercial Officer acquired 15,137 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wettig Thane Chief Commercial Officer 2023-03-08 Sale −6,265 $21.16 $132,542 104,090 D: show line 1 in the form
Wettig Thane Chief Commercial Officer 2023-03-08 Grant or award +5,799 109,889 D: show line 2 in the form
Wettig Thane Chief Commercial Officer 2023-03-08 Grant or award +9,338 119,227 D: show line 3 in the form
Wettig Thane Chief Commercial Officer 2023-03-10 Sale −2,938 $20.20 $59,340 116,289 D: show line 4 in the form
Wettig Thane Chief Commercial Officer 2023-03-10 Sale −4,731 $20.20 $95,553 111,558 D: show line 5 in the form
Open-market sales · 13,934 sh · avg $20.63 · $287,435
Loading xslF345X03/doc4.xml…